中国儿童遗尿症疾病管理专家共识（2025年）

129 : 405-410. doi: 10.1016/s0022-5347(17)52127-8pmid: 6834523 [62] Dutra MF， 2012 : 509012. [13] Rangel RA， risk factors， 2011 ， Lee JH。

Austin JC， et al. Canadian Urological Association guideline for the treatment of bladder dysfunction in children.[J] Can Urol Assoc J 。

Caldwell PH， Mosholder AD， 25 (1): 84-92. doi: 10.5213/inj.2040398.149pmid: 33819961 [23] National Clinical Guideline Centre (UK). Nocturnal Enuresis: The Management of Bedwetting in Children and Young People [M]. London: Royal College of Physicians (UK); 2010 . [24] Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents[J]. BJU Int ， 2021 ， 2019 ， 2008 ， et al. Opti-mizing response to desmopressin in patients with monosymptomatic noc turnal enuresis[J]. Pediatr Nephrol ， diagnosis。

Park JM。

et al. Desmopressin plus anti-cholinergic agent in the treatment of nocturnal enuresis: a meta-analysis[J]. Exp Ther Med ， et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children's continence society[J]. J Urol ， 50 (2): 136-151. doi: 10.1590/S1677-5538.IBJU.2023.0618pmid: 38386785 [63] Mcgrath KH， et al. Clinical utility of β3-adrenoreceptor agonists for the treatment of overactive bladder: a review of the evidence and current recommendations[J]. Res Rep Urol ， Atala A. A randomized。

2017 ， Cao L， Stewart F， 5 (5): CD002911. [43] Austin PF， 李晨， 23 (8): 991-1002. [51] Van Arendonk KJ， Lima GRMD， et al. Tuina for enuresis in children: a systematic review and meta-analysis of randomized controlled trials[J]. Front Public Health ， Saps M， 2006 。

Franco I， Tekgül S， Dos Santos J， Codarini M。

et al. Brazilian consensus in enuresis- recomendations for clinical practice[J]. Int Braz J Urol ， Koren A， Rondon AV， 2023 ， 14 (1): 4-8. Wang ZY。

et al. Prospective pilot study of mirabegron in pediatric patients with overactive bladder[J]. Eur Urol ， 12 (1): 1-2. doi: 10.1007/s11934-010-0150-4pmid: 20972651 [45] Yu J。

34 (4): 1435-1444. [16] Hyams JS， 2016 ， Blais AS， Du K， Stockner M。

Jobs K， 32 (2): 217-226. [34] Dalrymple RA。

Wang M， Rittig S， 2017 ， et al. Desmopressin withdrawal strategy for pediatric enuresis: a meta-analysis[J]. Pediatrics ， Van Herzeele C， Amjadzadeh M. A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with solifenacin plus desmopressin， 2018 ， et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society[J]. Neurourol Urodyn ， 102 (5): e215-e220. [67] Dal Pra A， Takada M， 2019 ， alarm， Carlsson CA。

Ferguson G， 2017 ， Daryanto B， Skugarevská B， 38 (2): 478-498. [38] Lucchini B， 2020 ， et al. Practical recommen-dations of the eau‐espu guidelines committee for monosymptomatic enuresis—bedwetting[J]. Neurourol Urodyn ， 2003 ， Jung AY， Umino D， 2022 ， desmopressin plus alarm， He Q， 122 (5): 1027-1032. doi: 10.1542/peds.2007-3691pmid: 18977983 [44] Hodges SJ， Wang M， et al. Exploration of the optimal desmopressin treatment in children with monosymptomatic nocturnal enuresis: evidence from a Chinese cohort[J]. Front Pediatr . 2021 。

Li C， 2008 ， 2013 ， Hervé F， et al. Quality of life in enuretic children[J]. Int Braz J Urol 。

Sun W， 44 (1-2): 19-27. [64] Hodges SJ。

35 (1): 58-61. [61] Lindström S， 16 (1): 10-19. [7] Bastos JM Netto， Paturej A， Bolduc S. Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children[J]. Expert Opin Pharmacother ， Hagstroem S， et al. Alarm interventions for nocturnal enuresis in children [DB/J]. Cochrane Database Syst Rev ， 2024 。

2023 ， 2021 ， 9 (6 Pt B): 1049-1053. doi: 10.1016/j.jpurol.2013.02.012pmid: 23619353 [39] Schulman SL， 等. 中国儿童单症状性夜遗尿疾病管理专家共识[J]. 临床儿科杂志 ， 陈朝英， 27 (8): 693-694. [58] Pillai RR， 2016 ， 2018 ， 15 (2): 81-86. [15] Zhong S， Raes A， 2025 ， Ergin G， Wacogne ID. Gradual withdrawal of desmopressin in patients with enuresis leads to fewer relapses than an abrupt withdrawal[J]. Arch Dis Child Educ Pract Ed ， 35 (4): 471-481. [6] Nevéus T， and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis[J]. BJU Int ， et al. Clinical practice guidelines for pediatrics in traditional chinese medicine - enuresis in children (revised)[J]. Zhongyi Erke Zazhi ， 2020 ， 37 (2):161-175. pmid: 21557833 [68] Baeyens D， Liu XM， et al. International continence society consensus on the diagnosis and treatment of nocturia[J]. Neurourol Urodyn ， 2015 ， et al. Prevalence and quality of life of slovenian children with primary nocturnal enuresis[J]. Int J Nephrol ， 姚勇， 2020 ， 2019 ， et al. Management of nocturnal enuresis in Taiwan: Consensus statements of the Taiwan enuresis expert committee[J]. J Formos Med Assoc . 2019 ， Lapointe É， 99 (21): 1615-1620. The Pediatric Urodynamics and Pelvic Floor Group and the Urology Group of the Pediatric Surgery Branch of the Chinese Medical Association. Chinese Expert Consensus on Diagnosis and Treatment of Enuresis in Children[J]. Zhonghua Yixue Zazhi ， Chang SJ， 45 : 889-900. [8] Bogaert G， tolterodine plus desmopressin， 2017 ， 2021 ， 47 (1): 73-81. [48] Park SJ， Bower W， 2017 ， Pai KS， 182 (4 Suppl): 2022-2026. doi: 10.1016/j.juro.2009.03.068pmid: 19695616 [32] Ohtomo Y， 2022 ， 2002 ， (10): 970-975. Shen Q， 28 (6): 362-376. [11] 陶洋旭， Liang Y， 2023 。

et al. Childhood Functional Gastrointestinal Disorders: Child/Adolescent[J]. Gastroenterology 。

Lee JW. The prevalence and therapeutic effect of constipation in pediatric overactive bladder[J]. Int Neurourol J ， Ikeda H， 2023 。

17 (6): 643-652 [21] Iscan B， 2017 ， Truffa M， et al. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis[J]. J Urol ， et al. Expert Consensus on the Management of Monosymptomatic Nocturnal Enuresis in Chinese Children[J]. Linchuang Erke Zazhi ， Ahmadzade M， 2020 ， and desmopressin alone: a randomized controlled clinical trial[J]. Int Braz J Urol ， Yao Y， 179 (3): 1128-1131. doi: 10.1016/j.juro.2007.10.088pmid: 18206924 [27] Tsuji S， et al. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized， 2021 . [10] Harris J， 2007 ， Hagstroem S， Lipson A， 102 : 335. doi: 10.1136/archdischild-2017-313000pmid: 28468819 [35] VandeWalle J， et al. Urodynamic findings in children with primary refractory nocturnal enuresis: 10 years' experience of a tertiary center[J]. Health Sci Rep ， 2008 ， 2021 ， 155 (3): 432e4. [53] Rakowska-Silska M， 2012 ， Fu HD。

Yao Y。

Fonseca E， Ding J， Stein R， Yan Z， 2022 ， D'Haese L， Míka D， Kaneko K. Management of treatment-resistant nocturnal enuresis[J]. Pediatr Int ， 2022 ， 15 (4): 206-210. doi: 10.5213/inj.2011.15.4.206pmid: 22259734 [66] Borch L， comparative study[J]. World J Pediatr ， 刘小梅， 15 : S0016- 5085 (16)00181-5. [17] Vande Walle J， 37 (1): 22-27 pmid: 12745738 [37] Everaert K， 79 (2): 421-424. doi: 10.1016/j.urology.2011.10.015pmid: 22173180 [65] Kim JH， Di Lorenzo C， et al. Gradual tapering of desmopressin leads to better outcome in nocturnal enuresis[J]. Pediatr Int 。

et al. The prevalence of ADHD in children with enuresis: comparison between a tertiary and non-tertiary care sample[J]. Acta Paediatr . 2006 ， 2020 ， and psychological effects of primary nocturnal enuresis in Chinese young adults[J]. Int Neurourol J ， 等. 中医儿科临床诊疗指南·小儿遗尿症(修订)[J]. 中医儿科杂志 ， 2017 ， 16 (2): 195.e1-195.e7. [22] Hu HJ。

67 (5): 1049e54. [52] Gish P， 2014 ， 95 : 347-352. doi: 10.1080/08035250500434736pmid: 16497647 [69] Ding H， 14 (4): 2875-2884. [46] Cai T， 64 (1): e15328. [41] Song P， 2019 ， Tekgül S. Primary and secondary enuresis: pathophysiology， 2014 ， Ozkayın N. Evaluation of health-related quality of life and affecting factors in child with enuresis[J]. J Pediatr Urol ， et al. Evaluation of a new frequency-volume chart for children with primary monosymptomatic nocturnal enuresis: a prospective， 2013 。

易著文. 儿童肾脏病学 [M]. 北京: 人民卫生出版社， 1983 ， Nakagawa M. Efficacy of the novel selective b3-adrenoreceptor agonist vibegron for treatment-resistant monosymptomatic nocturnal enuresis in children[J]. Int J Urol ， Moore K。

Irkilata HC。

Kos N， 2020 ， 2020 ， Cury FL， 13 (1): 41.e1-41.e8. [70] Tong C， Boyt MA， 2019 ， Anthony EY. Occult megarectum-a commonly unrecognized cause of enuresis[J]. Urology ， Lin C， Gorodzinsky F， 65 (1): e15573. [28] Liu J， Yi ZW. Pediatric Nephrology [M]. Beijing: People's Medical Publishing House. 2018 . [50] Ramsay S， 2016 ， 70 (1): 9-13. [57] Fujinaga S， Silangcruz JM， Ferrarez CEPF， et al. Management and treatment of nocturnal enuresis—an updated standardization document from the international children's continence society[J]. J Pediatr Urol ， 2011 ， 2014 ， Miao Q， Ceschi A， Yan Y， Roeyers H。

2014 ， Simonetti GD。

de Bessa J Júnior， Stokes A， 138 (1): e20160495. [31] Marschall-Kehrel D， 11 : 1242777. [47] Ghanavati PM。

34 (4): 228-239. doi: 10.1089/acu.2022.0002pmid: 36046465 [72] 王仲易， 45 (5): 369-373. Tao YX， double-blind， 2001 ， double-blind。

et al. Desmopressin in combination with anticholinergic agents in the treatment of nocturnal enuresis: a systematic review and meta-analysis[J]. Front Pediatr 。

45 (5): 369-373. [12] Karničnik K， 李建军. 医疗共识制订方法:德尔菲法和名义小组法[J]. 国际眼科纵览 ， Tsai JD， 6 (10): e1626. doi: 10.1002/hsr2.1626pmid: 37829504 ， 118 (6):965-972. [3] 中华医学会小儿外科学分会小儿尿动力和盆底学组和泌尿外科学组. 儿童遗尿症诊断和治疗中国专家共识[J]. 中华医学杂志 ， Petros PE. A four month squatting-based pelvic exercise regime cures day/night enuresis and bowel dysfunction in children aged 7-11 years[J]. Cent European J Urol ， 2024 ， Dos Santos J. Evaluation and manage-ment of enuresis in the general paediatric setting[J]. Paediatr Child Health ， Yang SS， 39 (2): 489-497. [9] The Japanese Society of Nocturnal Enuresis. Nocturnal Enuresis Clinical Practice Guidelines [M]. Tokyo: Diagnosis and Treatment Press， Sara B. Effectiveness of bladder retraining programme on bedwetting frequency and relapse rate of children with nocturnal enuresis[J]. J Pediatr Urol ， 2017 ， 杜可， 1983 。

等. 醋酸去氨加压素中长程疗法治疗儿童原发性单症状夜遗尿症疗效研究[J]. 中国实用儿科杂志 ， Rittig S。

et al. Efficacy of Long-term desmopressin acetate therapy for primary monosymptomatic nocturnal enuresis in children[J]. Zhongguo Shiyong Erke Zazhi 。

57 (4): 656-658. doi: 10.1111/ped.12614pmid: 25728739 [33] Kamperis K。

et al. Periaqueductal gray subregions connectivity and its association with micturition desire-awakening function[J]. Eur Child Adolesc Psychiatry ， et al. Adenotonsillectomy can decrease enuresis and sympathetic nervous activity in children with obstructive sleep apnea syndrome[J]. J Pediatr Urol 。

Bauer SB， 14 : 167-175. doi: 10.2147/RRU.S309144pmid: 35502186 [56] Blais AS， Nurhadi P. Monosymptomatic nocturnal enuresis treatment using alarm-therapy and desmopressin: a meta-analysis approach[J]. Med Arch ， Wang Y， Hu K。

et al. Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study[J]. Pediatr Nephrol ， Li JJ. Methods for developing medical consensus: Delphi method and nominal group technique[J]. Guoji Yanke Zonglan ， Watanabe Y， 32 (11): 861-865. Chu M， 29 (7): 1195-1200. doi: 10.1007/s00467-014-2751-5pmid: 24477979 [49] 徐虹， 2009 ， Bower WF， 10 : 821781. [71] Ton G， 2018 . Xu H， Chen ZY， [1] 沈茜， 2009 。

Bauer SB， 15 (2): 13-18. [55] Krhut J。

Ni J， 2020 ， 20 (4): 602.e1-602.e12. [59] Garcia-Fernandez A。

et al. Bladder and bowel dysfunction and the resolution of urinary incontinence with successful management of bowel symptoms in children[J]. Acta Paediatr ， Narouie B， 123 (3): 388-400. doi: 10.1111/bju.14539pmid: 30216627 [42] Caldwell PH。

15 (02): 81-86. Chinese Cooperative Group for the Management of Pediatric Enuresis Affiliated to Pediatric Nephrology Committee of Chinese Medical Doctor Association. Prevalence of nocturnal enuresis in children and adolescents aged 5 to 18 years in China[J]. Zhongguo Xunzheng Erke Zazhi ， 2021 。

2022 ， Seabra CR， Undre S， and treatment[J]. Eur Urol Focus ， Huang C， 2 (3): 232-238. pmid: 18690973 [36] Wolfish NM， et al. The Canadian enuresis study and evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation[J]. Scand J Urol Nephrol ， Souhami L. Radiation therapy and androgen deprivation in the management of high risk prostate cancer[J]. Int Braz J Urol ， Bosch R， Ono T。

placebo-controlled trial of anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis[J]. Curr Urol Rep ， 2021 ， Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis[J]. J Urol 。

et al. The neurophysiological basis of bladder inhibition in response to intravaginal electrical stimulation[J]. J Urol ， 2016 ， et al. Comparison of desmopressin， et al. The effectiveness of parasacral transcutaneous electrical nerve stimulation in the treatment of monosymptomatic enuresis in children and adolescents: a systematic review[J]. Int Braz J Urol ， et al. Comparison of wireless and wired alarm devices for nocturnal enuresis treatment[J]. Pediatr Int ， 8 : 626083. [29] 初梅，。

2016 。

Zhang ZW， et al. Enuresis: practical guidelines for primary care[J]. Br J Gen Pract ， 75 (6): 431-435. doi: 10.5455/medarh.2021.75.431-435pmid: 35169370 [26] Kamperis K， 166 (6): 2427-2431. pmid: 11696804 [40] Watanabe T。

Ho M， Jones MP. The frequency of constipation in children with nocturnal enuresis: a comparison with parental reporting[J]. J Paediatr Child Health ， Nadeau G， 3 (2-3): 198-206. doi: S2405-4569(17)30202-Xpmid: 28888814 [19] Koff SA. Estimating bladder capacity in children[J]. Urology ， 2020 ， 89 (4): 420-425. doi: 10.1046/j.1464-4096.2001.01546.xpmid: 11872036 [25] Purnomo AF， 14 : 1179556520975035. [54] Afshar K。

Barkin J， et al. Prevalence， et al. The Biofeedback Treatment for Non-Monosymptomatic Enuresis Nocturna[J]. Neurourol Urodyn ， 丁洁， Harms TW. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children[J]. J Urol ， Zhou S， 191 (6): 1863-1865. doi: 10.1016/j.juro.2014.01.110pmid: 24508614 [5] Austin PF， Wang DJ， 曹力， 73 (3): 307-314. doi: 10.5173/ceju.2020.0044pmid: 33133658 [60] Ebiloglu T， Lin X， et al. Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review[J]. J Pediatr Urol ， Ho W， 14 (1): 4-8. [73] Sharifiaghdas F。

et al. Voiding disorders in pediatrician’s practice[J]. Clin Med Insights Pediatr ， et al. Desmopressin 30 years in clinical use: a safety review[J]. Curr Drug Saf 。

Fall M， 99 (21): 1615-1620. [4] Austin PF。

Khazaeli D， 67 (660): 328-329. [18] Haid B， 2021 ， et al. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases[J]. J Pediatr ， et al. The effects of laser acupuncture therapy on nocturnal enuresis: a systematic review and meta-analysis[J]. Med Acupunct ， 21 (3): 248. doi: 10.1016/0090-4295(83)90079-1pmid: 6836800 [20] Wang JJ， Rittig S， 2011 ， et al. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder[J]. Urology ， 47 (3): 535-541. [14] 中国医师协会儿科医师分会肾脏疾病学组中国儿童遗尿疾病管理协作组. 中国5-18岁人群遗尿症患病率的横断面调查[J]. 中国循证儿科杂志 ， Bower W， 32 (11): 861-865. [30] Chua ME， 2021 。

(10): 970-975. [2] Wang TM， placebo-controlled trial[J]. Pediatrics 。